Skip to main content

Table 1 Characteristics of study population

From: Epidemiological profiles of patients with chronic migraine and chronic tension-type headache

 

No headache

EM

CM

ETTH

CTTH

 

N = 4030

N = 1601

N = 108

N = 1203

N = 50

age, years

mean, (SD)

46.7 (12.8)

40.4 (11.8)

45.3 (12.9)

41.1 (12.6)

49.4 (13.9)

min, max

18, 66

5, 66

18, 66

18, 66

19, 65

missing, N

2

1

0

1

0

gender, N (%)

men

2408 (59.8)

466 (29.1)

29 (26.9)

505 (42.0)

26 (52.0)

women

1622 (40.2)

1135 (79.9)

79 (73.1)

698 (58.0)

24 (48.0)

missing

0

0

0

0

0

drinking a , N (%)

no

3086 (76.6)

1467 (91.6)

97 (89.8)

1069 (89.0)

38 (76.0)

yes

555 (13.8)

106 (6.6)

8 (7.4)

115 (9.5)

11 (22.0)

missing

389 (9.6)

28 (1.8)

3 (2.8)

19 (1.5)

1 (2.0)

smoking b , N (%)

no

2581 (64.0)

1071 (66.9)

62 (57.4)

839 (69.7)

32 (64.0)

yes

1075 (26.7)

513 (32.0)

44 (40.7)

350 (29.1)

17 (34.0)

missing

374 (9.3)

17 (1.1)

2 (1.9)

14 (1.2)

1 (2.0)

education c , N (%)

high*

1005 (24.9)

548 (34.2)

20 (18.5)

470 (39.1)

12 (24.0)

low

2587 (64.1)

1018 (63.6)

86 (79.6)

715 (59.4)

38 (76.0)

missing

438 (12.1)

35 (2.2)

2 (1.9)

18 (1.5)

0 (0)

BMI, N (%)

< 30

3090 (76.7)

1367 (85.4)

88 (81.5)

1044 (86.8)

43 (86.0)

≥ 30

479 (11.9)

192 (12.0)

19 (17.6)

129 (10.7)

5 (10.0)

missing

461 (11.4)

42 (2.6)

1 (0.9)

30 (2.5)

2 (4.0)

frequent medication intake d , N (%)

yes

74 (1.8)

105 (6.6)

54 (50.0)

33 (2.7)

15 (30.0)

no

3442 (85.4)

1337 (83.5)

41 (38.0)

1056 (87.8)

30 (60.0)

missing

514 (12.8)

159 (9.9)

13 (12.0)

114 (9.5)

5 (10.0)

  1. a Drinking (yes) was defined as daily or almost daily drinking of alcoholic beverage and drinking (no) was defined as no or casual drinking of alcoholic beverage.
  2. b Smoking (yes) was defined as current smoking and smoking (no) was defined as never or past smoking.
  3. c High education was defined as completion high school or University and low as any other response.
  4. d Frequent medication intake was defined as intake of acute pain drugs on ≥15 days per month.